Literature DB >> 26290627

Signs and genetics of rare cancer syndromes with gastroenterological features.

William Bruno1, Giuseppe Fornarini1, Paola Ghiorzo1.   

Abstract

Although the genetic bases of most hereditary cancer syndromes are known, and genetic tests are available for them, the incidence of the most rare of these syndromes is likely underestimated, partially because the clinical expression is neither fully understood nor easily diagnosed due to the variable and complex expressivity. The clinical features of a small pool of rare cancer syndromes include gastroenterological signs, though not necessarily tumors, that could require the intervention of a gastroenterologist during any of the phases of the clinical management. Herein we will attempt to spread the knowledge on these rare syndromes by summarizing the phenotype and genetic basis, and revising the peculiar gastroenterological signs whose underlying role in these rare hereditary cancer syndromes is often neglected. Close collaboration between geneticists and gastroenterologists could facilitate both the early identification of patients or relatives at-risk and the planning of multidisciplinary and tailored management of these subjects.

Entities:  

Keywords:  Diagnostic criteria; Gastroenterological features; Genetic susceptibility; Genetic testing; Rare cancer syndromes

Mesh:

Substances:

Year:  2015        PMID: 26290627      PMCID: PMC4533032          DOI: 10.3748/wjg.v21.i30.8985

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  81 in total

1.  Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes.

Authors:  Julie Hallet; Calvin How Lim Law; Moises Cukier; Refik Saskin; Ning Liu; Simron Singh
Journal:  Cancer       Date:  2014-10-13       Impact factor: 6.860

Review 2.  Hereditary Non-Polyposis Colorectal Cancer: the rise and fall of a confusing term.

Authors:  Jeremy R Jass
Journal:  World J Gastroenterol       Date:  2006-08-21       Impact factor: 5.742

3.  Beckwith-Wiedemann syndrome: growth pattern and tumor risk according to molecular mechanism, and guidelines for tumor surveillance.

Authors:  F Brioude; A Lacoste; I Netchine; M-P Vazquez; F Auber; G Audry; M Gauthier-Villars; L Brugieres; C Gicquel; Y Le Bouc; S Rossignol
Journal:  Horm Res Paediatr       Date:  2013-12-04       Impact factor: 2.852

4.  Familial carcinoid tumors and subsequent cancers: a nation-wide epidemiologic study from Sweden.

Authors:  K Hemminki; X Li
Journal:  Int J Cancer       Date:  2001-11-01       Impact factor: 7.396

5.  Malignant carcinoids in the USA, SEER 1992-1999. An epidemiological study with 6830 cases.

Authors:  E Crocetti; E Paci
Journal:  Eur J Cancer Prev       Date:  2003-06       Impact factor: 2.497

6.  Prevalence of breast and colorectal cancer in Ashkenazi Jewish carriers of Fanconi anemia and Bloom syndrome.

Authors:  Hagit N Baris; Inbal Kedar; Gabrielle J Halpern; Tamy Shohat; Nurit Magal; Mark D Ludman; Mordechai Shohat
Journal:  Isr Med Assoc J       Date:  2007-12       Impact factor: 0.892

Review 7.  von Hippel-Lindau disease.

Authors:  Russell R Lonser; Gladys M Glenn; McClellan Walther; Emily Y Chew; Steven K Libutti; W Marston Linehan; Edward H Oldfield
Journal:  Lancet       Date:  2003-06-14       Impact factor: 79.321

8.  Ameloblastoma: a neglected criterion for nevoid basal cell carcinoma (Gorlin) syndrome.

Authors:  Giovanni Ponti; Lorenza Pastorino; Annamaria Pollio; Sabina Nasti; Giovanni Pellacani; Michele D Mignogna; Aldo Tomasi; Corrado Del Forno; Caterina Longo; Giovanna Bianchi-Scarrà; Guido Ficarra; Stefania Seidenari
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

9.  Hereditary hemorrhagic telangiectasia: multi-detector row helical CT assessment of hepatic involvement.

Authors:  Amato Antonio Stabile Ianora; Maurizio Memeo; Carlo Sabba; Anna Cirulli; Antonio Rotondo; Giuseppe Angelelli
Journal:  Radiology       Date:  2003-11-26       Impact factor: 11.105

Review 10.  Multiple endocrine neoplasia type 1.

Authors:  Francesca Marini; Alberto Falchetti; Francesca Del Monte; Silvia Carbonell Sala; Alessia Gozzini; Ettore Luzi; Maria Luisa Brandi
Journal:  Orphanet J Rare Dis       Date:  2006-10-02       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.